TYK Medicines reports new compounds for preventing and/or treating neurodegenerative disease
Aug. 1, 2024
TYK Medicines Inc. has patented compounds reported to be useful for the treatment of Alzheimer’s, Parkinson’s and Huntington diseases as well as amyotrophic lateral sclerosis, epilepsy and spinocerebellar ataxia.